Multiple Cranial Neuropathies After Lenvatinib–Pembrolizumab Therapy for Metastatic Renal Cell Carcinoma: A Case Report
We report a rare case of multiple cranial nerve palsies that developed during lenvatinib-pembrolizumab therapy. Such neuropathies typically occur early, respond to corticosteroids, and require careful monitoring, as retreatment may lead to recurrence or new adverse events.
Authors
- Hideyuki Minagawa
- Tomoyuki Kaneko (ORCID: https://orcid.org/0000-0002-5762-7563)
- Kenjiro Kishitani
- Tohru Nakagawa (ORCID: https://orcid.org/0000-0003-4041-7241)
- Risako Yagi
- Kazuki Takei
- Keiichi Hokkoku
- Inoue Hazuki
- Ayano Miyashima
- Ono Tenei
Institutions
- Teikyo University (JP)
Publication Details
- Journal
- IJU Case Reports
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1002/iju5.70136
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 24.20